Precision Medicine

Best Hospital IT 2016 CIOs
By Mike Miliard 07:05 am November 23, 2016
Healthcare IT News took the pulse of its Best Hospital IT Departments 2016 winners and found that progress on these fronts is fluctuating – from ‘dabbling’ today to leading-edge work toward next-generation care delivery.
Intel Broad MIT Harvard
By Jessica Davis 04:42 pm November 17, 2016
The five-year partnership will focus on best practices for genomics analytics and collaborating on tools to better process and integrate data.
OIG HHS NIH security
By Jessica Davis 01:28 pm November 15, 2016
As outlined in HHS Office of Inspector General's 2017 work plan, the agency will also review the FDA's plan to address cybersecurity issues of medical devices.
artificial pancreas
By 12:58 pm November 11, 2016
The project will combine an insulin pump, continuous glucose monitoring and personalized medicine technologies, the companies said. 
By Jessica Davis 11:08 am November 10, 2016
Mayo Clinic and biotechnology firm Illumina will collaborate on next-generation sequencing technology to further Mayo's genetic and genomic research, the orgnizations announced today.
Precision medicine
By Jessica Davis 02:05 pm November 07, 2016
Two recent studies have highlighted issues related to the reliability of genetic testing, and a lack of genomic data from minority populations.
By Bernie Monegain 12:23 pm November 07, 2016
David A. Williams, MD, an internationally-recognized pediatric hematologist and oncologist, has been named Boston Children¹s Hospital¹s first chief scientific officer.
Precision BI VitreosHealth
By Jack McCarthy 10:26 am November 01, 2016
Companies say the new service will include clinical and financial analytics to enable customers to control costs and improve outcomes in the MACRA era. 
By Mike Miliard 10:32 am October 28, 2016
With research institutions 'choking on data,' new precision medicine technology helps researchers manage large volumes.

Ingo Chakravarty, a 26-year senior healthcare executive, will lead Navican as president and CEO.

By Bernie Monegain 03:37 pm October 24, 2016
The company will use a sequencing test developed by the health system to find and target individual mutations within cancer tumors.

Most Read

The Daily Brief Newsletter